Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of Prestwick3_000218 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Prestwick3_000218

    ACTIVE PHARMA INGREDIENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    26/09/2024 DINAMITE DIPHARMA SPA 8034 FENBUFEN 1989-04-25 Inactive II N/A
    26/09/2024 LEDERLE LABORATORIES DIV AMERICAN CYANAMID CO 4892 FENBUFEN MNFG BY CYANAMID OF GREAT BRITAIN, LIMITED 1982-12-27 Inactive II N/A